QS Investors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-54,280
| Closed | -$852K | – | 1675 |
|
|
2019
Q1 | $852K | Sell |
54,280
-16,410
| -23% | -$258K | 0.01% | 855 |
|
|
2018
Q4 | $1.09M | Buy |
70,690
+67,280
| +1,973% | +$1.04M | 0.01% | 743 |
|
|
2018
Q3 | $73K | Sell |
3,410
-1,000
| -23% | -$21.4K | ﹤0.01% | 1447 |
|
|
2018
Q2 | $107K | Sell |
4,410
-4,800
| -52% | -$116K | ﹤0.01% | 1392 |
|
|
2018
Q1 | $157K | Sell |
9,210
-11,880
| -56% | -$203K | ﹤0.01% | 1261 |
|
|
2017
Q4 | $400K | Sell |
21,090
-1,564
| -7% | -$29.7K | ﹤0.01% | 999 |
|
|
2017
Q3 | $399K | Sell |
22,654
-67,647
| -75% | -$1.19M | ﹤0.01% | 1017 |
|
|
2017
Q2 | $3M | Buy |
90,301
+7,543
| +9% | +$251K | 0.03% | 462 |
|
|
2017
Q1 | $2.66M | Buy |
82,758
+1,097
| +1% | +$35.2K | 0.02% | 518 |
|
|
2016
Q4 | $2.96M | Buy |
81,661
+6,680
| +9% | +$242K | 0.02% | 501 |
|
|
2016
Q3 | $3.45M | Buy |
74,981
+9,014
| +14% | +$415K | 0.03% | 495 |
|
|
2016
Q2 | $3.31M | Sell |
65,967
-140,974
| -68% | -$7.08M | 0.03% | 513 |
|
|
2016
Q1 | $11.1M | Buy |
206,941
+513
| +0.2% | +$27.5K | 0.11% | 184 |
|
|
2015
Q4 | $13.6M | Sell |
206,428
-2,038
| -1% | -$134K | 0.13% | 143 |
|
|
2015
Q3 | $11.8M | Sell |
208,466
-5,178
| -2% | -$292K | 0.12% | 159 |
|
|
2015
Q2 | $12.6M | Buy |
213,644
+18,577
| +10% | +$1.1M | 0.16% | 150 |
|
|
2015
Q1 | $12.2M | Buy |
195,067
+45,933
| +31% | +$2.86M | 0.14% | 175 |
|
|
2014
Q4 | $8.58M | Buy |
149,134
+131,593
| +750% | +$7.57M | 0.1% | 235 |
|
|
2014
Q3 | $943K | Sell |
17,541
-25,020
| -59% | -$1.35M | 0.03% | 361 |
|
|
2014
Q2 | $2.23M | Buy |
42,561
+38,426
| +929% | +$2.01M | 0.06% | 250 |
|
|
2014
Q1 | $218K | Sell |
4,135
-865
| -17% | -$45.6K | 0.01% | 575 |
|
|
2013
Q4 | $200K | Buy |
+5,000
| New | +$200K | 0.01% | 567 |
|